Springer Nature
Browse

sorry, we can't preview this file

40425_2018_450_MOESM1_ESM.docx (114.82 kB)

Additional file 1: of Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy

Download (114.82 kB)
journal contribution
posted on 2018-11-27, 05:00 authored by Natalie Miller, Candice Church, Steven Fling, Rima Kulikauskas, Nirasha Ramchurren, Michi Shinohara, Harriet Kluger, Shailender Bhatia, Lisa Lundgren, Martin Cheever, Suzanne Topalian, Paul Nghiem
Serology results. Raw results for MCPyV-specific oncoprotein antibodies were reported as Standard Titer Units (STUs). Patient with a value of 75 or greater were considered oncoprotein antibody producers and values below 74 were considered negative. Abbreviations for RECIST 1.1 response criteria are as follows: CR = complete response; PR = partial response; PD = progressive disease. (DOCX 114 kb)

Funding

National Cancer Institute

History

Usage metrics

    Springer Nature

    Categories

    Keywords

    Merkel cell carcinomaMerkel cell polyomavirusViral cancer antigenImmunotherapyPembrolizumabAnti-PD-1T cell

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC